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Abstract
Background: Lead-exposed workers may suffer adverse health effects under the currently regulated blood lead
(BPb) levels. However, a probabilistic assessment about lead exposure-associated anemia risk is lacking. The goal of
this study was to examine the association between lead exposure and anemia risk among factory workers in Taiwan.
Methods: We first collated BPb and indicators of hematopoietic function data via health examination records that
included 533 male and 218 female lead-exposed workers between 2012 and 2014. We used benchmark dose (BMD)
modeling to estimate the critical effect doses for detection of abnormal indicators. A risk-based probabilistic model was
used to characterize the potential hazard of lead poisoning for job-specific workers by hazard index (HI). We applied
Bayesian decision analysis to determine whether BMD could be implicated as a suitable BPb standard.
Results: Our results indicated that HI for total lead-exposed workers was 0.78 (95% confidence interval: 0.50–1.26) with
risk occurrence probability of 11.1%. The abnormal risk of anemia indicators for male and female workers could be
reduced, respectively, by 67–77% and 86–95% by adopting the suggested BPb standards of 25 and 15 μg/dL.
Conclusions: We conclude that cumulative exposure to lead in the workplace was significantly associated with anemia
risk. This study suggests that current BPb standard needs to be better understood for the application of lead-exposed
population protection in different scenarios to provide a novel standard for health management. Low-level lead
exposure risk is an occupational and public health problem that should be paid more attention.
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Background
The adverse health effects of lead exposure have been
known for centuries. Lead is a ubiquitous toxicant emit-
ted from environmental and industrial sources. Exposure
routes of lead uptake in the workplace include ingestion
and inhalation of inorganic lead. Therefore, the major
sources of lead exposure may come from dust, fume,
and poor personal hygiene including eating and smoking
through contaminated hands. Many biomonitoring
methods are capable of measuring the bioaccumulation
of lead in the human body [1]. Lead levels in bone,
blood, urine, and exfoliated teeth are the major bio-
markers of internal dose. Nowadays, blood lead (BPb)
measurement is still the primary technique to investigate
recent lead accumulation in the body. Recently, lead
condensate in exhaled breath was also shown to be a
suitable non-invasive biomarker of occupational expos-
ure in recent years [2].
Lead poisoning is considered the most well character-
ized occupational disease. The inhaled/ingested lead
can transport to the heart, bones, intestines, kidneys,
reproductive, and nervous systems, causing tissue-
specific adverse effects [3, 4]. Implements of industrial
hygiene and control measures have significantly de-
creased workers’ BPb concentrations over the last few
decades [5, 6]. However, recent studies indicate that
lead-exposed workers may suffer from adverse health
effects under the current standards [7–9]. Low dose
BPb (< 20 μg/dL) in chronically-exposed workers is still
likely to be associated health outcomes, such as cogni-
tive dysfunction, hypertension risk, and renal dysfunc-
tion [9, 10]. In recent years, these low-dose toxic effects
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of lead have received considerable attention, thereby
questioning the capability of the current standard for
critical dose of lead to protect the health of lead-
exposed population. The issue not only in lead indus-
tries, but it also causes some problems in public health
in several areas [11–14].
Adverse hematological effects are some of the manifes-
tations of lead poisoning in lead workers. Chronic lead
poisoning inhibits the ability to produce hemoglobin by
interfering with enzymatic steps in the heme synthesis
pathway and diminishes red blood cells, thereby increas-
ing risk of anemia [15]. The absorption of lead can cause
iron deficiency and may further cause anemia. Anemia
associated with chronic lead exposure is a result of both
interferings with heme biosynthesis and by decreasing
red blood cell survival.
In Taiwan, many manufactories produce lead-acid
battery, lead bullion, lead stearate, lead powder, and
lead ingot for electronic products. Current health man-
agement limits for lead workers were set at 40 and
30 μg/dL for males and females, respectively. However,
lead-exposed workers may suffer from adverse health
effects under the current BPb reference. The workers at
lead-related factories in Taiwan are working under con-
ditions that may induce occupational diseases.
The main purpose of this study was to assess the risk
of anemia for workers in lead factories and to provide a
suggested BPb limit to improve health management for
lead workers. A probabilistic risk assessment approach
was used to estimate the BPb effect doses for abnormal
hematological indicators and to assess anemia risk asso-
ciated with exposure to lead. Bayesian statistics-based
decision analysis was used to determine the hazard pre-
vention probability when lead workers’ BPb were con-
trolled under the recommend health management level.
Methods
Study population
This study firstly collected the health examination data
that were sourced from annual regular health examin-
ation records from different lead factories between 2012
and 2014. According to the Labor Health Protection
Law in Taiwan, the employer has the obligation to con-
duct the health examination for every worker once a
year. Lead workers also need to receive the special phys-
ical and medical examinations. The examination items
were included the inspection of BPb and hematological
indicators of hematocrit (Hct), hemoglobin (Hgb), red
blood cell count (RBC), mean corpuscular volume
(MCV), mean corpuscular hemoglobin (MCH), and
mean corpuscular hemoglobin concentration (MCHC)
[16]. Some other information such as gender, birthdate,
start working date and manufacturing area were also
been recorded. Based on the Labor Health Protection
Law, lead workers were asked to complete the question-
naire of special physical and the medical examination
that included five items of demographic data, working
experience, past medical history, living habits, and self-
perceived symptoms. To characterize exposure history,
we collected birth dates, dates of employment and
examination records from the subjects. Work experience
was used to describe the past and current working pro-
cesses to further characterize exposure history. Accord-
ing to these information, the job-specific exposure
conditions were calculated based on the working areas
for each lead worker.
The total of 533 male and 218 female lead-exposed
workers’ data were collected to construct the dataset,
sourcing from 6 factories with different manufactory
types (Table 1). The average ages of male and female
workers were 43.7 (sd: 10.2) and 47.1 (8.6) yrs. All 533
male workers were working in the lead battery, lead
stearate, and lead bullion factories, respectively. All 218
female workers were working in lead battery factories.
Within a lead battery factory, the manufacturing areas
were classified as casting, grinding, powder, filling, for-
matting, cutting, assembling, charging, packaging, or
other off-site positions. The job-specific exposure condi-
tions were calculated based on the working areas for
lead workers.
Benchmark dose-based effect analysis
We used the health examination record to construct
the dose-response relationships between BPb levels
and adverse hematological indicators. We used correl-
ation analysis is the preliminary exam in effect analysis
that allows us to understand the strength between the
effect factors and anemia-associated indicators. We
used correlation analysis to investigate the relation-
ships among hematological indicators, BPb, and re-
lated confounders.
Hematological indicators have the reference ranges in
the clinical medicine that can be used to diagnose the
conditions of hematopoietic system. This study adopted
these reference ranges to calculate the number and pro-
potion of normal and abnormal lead workers in male
and female populations. For estimating the critical effect
dose of BPb for lead-associated abnormal hematological
indicator, we employed the benchmark dose (BMD)
models that have been used in many previous risk as-
sessment studies [16].
We calculated the dichotomous response from quantal
data using BMD models, as summarized in Table S1 (see
Additional file 1). The benchmark response (BMR) was
set to an abnormal proportion of 10% (BMR10) in the
dose-response relationshi, as a conservative approach to
protect the health of lead-exposed.
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Rick characterization
Health risk of anemia for workers at job-specific working
areas was calculated by using a joint probability function
combining the predicted BMD10 as acceptable risk limits
and BPb concentration. We used a Monte Carlo (MC)
approach to generate the large number of simulated
samples of BPb and to understand the most likely BPb
value in each job category. We considered the potential
sources of variability and uncertainty in the BPb distri-
butions as a probability density function based on mea-
sured values.
This study calculated the hazard index (HI) as poten-
tial health risk as follow,
P HIð Þ ¼ P BPbð Þ
P BMDð Þ : ð1Þ
The estimated BMDs were further treated probabilis-
tically by considering the BMD10 and BMDL10, repre-
senting the mean and lower levels of 95% confidence
interval (CI), respectively. HI > 1 implies that unaccept-
able health risk of anemia will occur for lead-exposed
workers in the specific working group and HI < 1 indi-
cates acceptable health risk with the proportion of health
effect <10%.





HI i  pið Þ; ð2Þ
where pi is the proportion of lead-exposed worker in the
specific job category. Thus, hazard occurrence probabil-
ity can be calculated by using the proportion of simu-
lated HI which value is greater than 1.
The risk contribution of job (Rjob, %) can be estimated as,
Rjob ¼ HIi  piTR : ð3Þ
Bayesian decision analysis
To determine whether the proposed BMD can be used
as a novel BPb limit for lead exposed-associated risk
management, this study applied a Bayesian decision
approach that has been widely used in the probabilistic-
based statistical method in decision making [17]. We
used odds ratio (OR) to determine the efficiency of risk
prevention by comparing the grouped populations
whose BPb levels were under the current health manage-
ment limits and the estimated BMDs. After that, this
study conducted the product of binomial likelihood that
sourced from collected health examination data as Y0 ~
binomial (π0, n0) and Y1 ~ binomial (π1, n1) with the
parameters of interest as θ = (π0, π1) where Y0 and Y1
are the observed normal and abnormal individuals in in-
dicators of hematopoietic function. The parameters of
π0 and π1 are the ratio of normal and abnormal
hematological indicators in the subpopulation number
of n0 and n1, respectively. The OR was estimated as,
OR ¼ π1 1−π0ð Þ
π0 1−π1ð Þ : ð4Þ
We assumed the beta priors for the occurred prob-
abilities π0 and π1 with parameters (a0, b0) and (a1, b1),
respectively. The posterior can be given by (π0| y) ~ beta (y0
+ a0, n0 + b0) and (π1| y) ~ beta (y1 + a1, n1 + b1). Estima-
tion of the posterior distribution of ORs can be simply ob-
tained by simulating the distribution of f(π0| y) and f(π1| y).
Finally, hazard prevention probability was calculated by
using the proportion of simulated ORs. To prevent the
confounding factors that may cause abnormal
hematological indicators with lower occupational lead
Table 1 Basic statistics of age, working years, BPb levels, and indicators of hematopoietic function for 533 male and 218 female
lead-exposed workers
Item Unit Mean (SD) Min – Max
Basic information
Age yrs 43.7 (10.2) / 47.1 (8.6)a 21–65 / 27–64
Working years yrs 11.8 (10.9) / 13.4 (9.7) 0–38 / 1–42
Blood lead μg/dL 21.4 (13.3) / 11.3 (5.7) 2.1–101.4 / 1.8–31.3
Hematopoietic function
Hematocrit % 44.8 (3.2) / 40.1 (3.6) 31.3–57.8 / 26.6–46.9
Hemoglobin g/L 15.11 (1.2) / 13.1 (1.4) 10.5–18.8 / 7.9–15.5
Red blood cell count ×106 /μL 5.16 (0.50) / 4.6 (0.4) 3.73–7.44 / 3.6–6.4
Mean corpuscular volume fl 87.4 (7.1) / 87.6 (8.6) 57–102 / 49.4–97.1
Mean corpuscular hemoglobin pg 29.5 (2.9) / 28.7 (3.4) 17.5–38.6 / 14.1–33.9
Mean corpuscular hemoglobin concentration % 33.8 (1.3) / 32.7 (1.3) 29.2–38.9 / 28.1–36.1
aMale/Female
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exposure, this study adjusted the estimation of ORs by
excluding the low-level BPb (< 5 μg/dL).
Uncertainty and data analysis
Statistics and regressions of this study were conducted
in the open source language R (Version 3.1.1, The R
Foundation for Statistical Computing). The p-value
<0.05 was considered to be statistically-significant. The
BMD models were performed by BMD software (Ver-
sion 2.5.1, USEPA) and followed the guidelines from
USEPA [18, 19]. The Cochran-Armitage test for trend
analysis was used to assess the presence of a dose-
response relationship. We chose the dose-response
dataset with p-value <0.05 to perform subsequent data
analysis.
The best-fitted model and associated BMD and BMDL
for each dose-response relation were selected based on
the Akaike’s information criterion (AIC) and p-value of
Chi-squared (χ2). The AIC was defined as penalized like-
lihood function as AIC = − 2 log L + 2p that p was the
number of parameters in the model and L is the max-
imum likelihood value.
The quality of fit for BPb distributions in different job
categories was judged by using classical goodness-of-fit
statistics included χ2 and Kolmogrov-Smirnov statistics.
This study took into account all BMD models that had
large p-value from Pearson χ2 goodness-of-fit statistics.
To integrate the risk estimates across different models,
the model-averaging BMD was applied by calculating
the weight wk. for each model as [20],
wk ¼ exp −0:5AICkð ÞPK
i¼1 exp −0:5AICið Þ
: ð5Þ
Thus, the model-averaged BMD and BMDL can be
calculated as μ BMDð Þ ¼PKk¼1BMDk⋅wk and μ BMDLð Þ
¼PKk¼1BMDLk⋅wk , respectively. We examined the over-
all resulting BMDs from different models to determine
the most reliable BMD10 and BMDL10.
Uncertainty is a key factor in risk assessment that can
influence the precision of risk estimation [21]. This
study considered the uncertainty and its impact on the
expected risk estimates that were quantified by MC
simulation. Each simulation was carried out with 10,000




Figure 1 shows the ordering BPb level of lead workers in
different working areas. Male workers in the lead battery
manufacturing processes of grinding, cutting, and filling
had relatively higher BPb concentrations than those in
other working areas. Median BPb concentrations were
estimated 24.5 and 25.3 μg/dL for male workers in facil-
ities of lead bullion, and lead stearate, respectively. The
highest BPb concentration was observed in lead stearate
factories. Compared with male workers, female workers
in lead battery factories had lower BPb levels.
The distributions of the abnormal number in
hematological indicators are shown in Table 2. We
found out that the abnormal proportion of indicator can
exceed 20% for male workers in the exposure groups of
grinding, powder, formatting, assembling, and charging,
whereas the abnormal proportion may exceed 20% for
female workers in every working group. Overall, the ab-
normal proportions ranged between 0 and 37.5% for
each subgroup.
Critical effect dose estimation
To investigate the association of specific hematological
indicators with BPbs, we performed a Pearson-based
correlation analysis (Fig. 2). The BPb was significantly
correlated with all hematological indicators, including
Hct (r = −0.38; p < 0.001), Hgb (r = −0.40; p < 0.001),
RBC (r = −0.18; p < 0.05), MCV (r = −0.19; p < 0.01),
MCH (r = −0.22; p < 0.01), and MCHC (r = −0.18;
p < 0.05) for male workers (Fig. 2a).
To determine the critical effect dose, we used BMDmodel-
ing to estimate the BPb levels that could associate with 10%
abnormal proportion of each hematological indicator.
ThroughCochran-Armitage trend test, our results found that
hematological indicators had significant dose-response trend
with BPb concentration in male workers, including Hct
(χ2 = 3.336; p < 0.01), Hgb (χ2 = 1.741; p < 0.05), MCV (χ2 =
3.879; p < 0.001), and MCH (χ2 = 3.343; p < 0.001) (see
Additional file 2: Tables S2 – S5). Among female
workers, hematological indicators had significant dose-
response trend for Hct (χ2 = 2.110; p < 0.05), RBC
Fig. 1 Boxplots ordering the job-specific BPb levels for male and
female workers in lead factories
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(χ2 = 1.849; p < 0.05), MCV (χ2 = 1.887; p < 0.05), and MCH
(χ2 = 2.472; p < 0.01) (see Additional file 2: Tables S6 – S9).
The model averaging BMD10 estimates were 53.5
(BMDL10: 40.5), 60 (44.5), 37.8 (22.1), and 42.0 μg/dL
(28.8) for Hct, Hgb, MCV, and MCH for male workers,
respectively (Tables S2 – S5). Among female workers,
model averaging BMD10 estimates were 8.6 (BMDL10:
5.5), 9.8 (6.3), 12.1 (9.4), and 10.7 μg/dL (7.9) for Hct,
RBC, MCV, and MCH, respectively (Tables S6 – S9).
Figure 3a shows that BMD10 were strongly correlated
with BMDL10 for male (r = 0.69) and female (r = 0.82)
workers. Based on MC simulation, the BMDs were
depicted as a probability density function of normal dis-
tribution that average BMD10 were 48.39 ± 11.58
(mean ± sd) and 10.26 ± 1.98 μg/dL for male and female
workers, respectively (Fig. 3b).
Anemia risk estimates
We found that the highest hazard occurrence probability
was in male grinding workers with median HI of 1.00
(95% CI: 0.39–1.80) (Fig. 4). For female workers, assem-
bling and packaging work groups had relatively higher
hazard occurrence probabilities of 80% and 60% with the
median HIs of 1.48 (0.47–2.67) and 1.32 (0.43–3.16), re-
spectively. The overall risk in HI for lead-exposed
workers was 0.78 (0.50–1.26) with hazard occurrence
probability of 11%. Risk contribution analysis indicated
that female workers in the assembling group contributed
a significant high risk to the total population, with a
contribution proportion of 31.5%. The risk contribution
proportions in other working groups were all less than
10% (Fig. 4).
Health management-based risk decision
Based on the probability distribution (Fig. 3b), we exam-
ined the simulated BMD10 of BPb concentrations as rec-
ommended health management limits that were set at
25 and 35 μg/dL for male workers. The recommended
standards for female workers were set at 10 and 15 μg/
dL. We used the recommended BMDs to compare with
the current health management limits that were 40 and
30 μg/dL for male and female workers, respectively.
Figure 5 shows the results of decision analysis. Con-
founding was addressed using data stratification. ORs
Table 2 Job-specific number of workers and the related abnormal number of hematological indicators in each job
aPercentage (%)
(white: <10%, light gray: 10–20%, and dark gray: > 20%)
Hsieh et al. BMC Public Health  (2017) 17:389 Page 5 of 12
ab
Fig. 2 Correlation matrix showing the relations among BPb level, age, working years, and indicators of hematopoietic function for lead-exposed
workers for (a) male and (b) female (represented as Pearson correlation coefficient: * p < 0.05, ** p < 0.01, *** p < 0.001)
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and adjusted ORs in male workers were 1.00 (95% CI:
0.84–1.18) and 1.10 (0.85–1.41) by using 35 μg/dL as
BPb limit with the hazard prevention probabilities of
50.6% and 76.2% under unadjusted and adjusted scenar-
ios, respectively. Moreover, when we adopted 25 μg/dL
as BPb limits, the results of ORs and adjusted ORs were
1.04 (0.88–1.23) and 1.09 (0.87–1.37) with the hazard
prevention probabilities of 67.0% and 76.9% under un-
adjusted and adjusted scenarios, respectively. ORs and
adjusted ORs were 1.19 (0.88–1.59) and 1.38 (0.95–1.97)
for female workers by using 15 μg/dL as BPb limit with
the hazard prevention probabilities of 85.5% and 95.0%
under unadjusted and adjusted scenarios, respectively
(Fig. 5). It can be seen that estimated ORs were relatively
higher when we adopted 15 μg/dL as BPb limit. The es-
timated ORs and adjusted ORs, respectively, were 0.96
(0.75–1.20) and 0.91 (0.70–1.18) when using 10 μg/dL
as BPb limit. The hazard prevention probabilities were
estimated 32.0% and 22.9% under unadjusted and ad-
justed scenarios, respectively.
Discussion
Risk quantification and decision
This study focuses on lead exposure-related anemia risk.
Therefore, we used hematological indicators to represent
BPb-induced anemia. The Hct, Hgb, and RBC were rep-
resentative indicators of lead-associated occupational
anemia and can be used to evaluate the critical BPb
levels to protect lead workers [16]. In addition to com-
mon indicators, our study also applied the measure-
ments of MCV, MCH, and MCHC, which were
calculated by three original indicators to estimate the
possible critical values.
This study found that BPb-related hematological ef-
fects of anemia were consistent with previous studies
[16, 22]. Even though numerous studies have
a
b
Fig. 3 a Scatter plot showing the relationships between effect doses of BMD and BMDL10 for male and female. b Distribution of BMD of BPb for
male and female lead workers
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demonstrated that BPb can induce adverse effects to the
hematological system, Pourabdian et al. [23] found that
indicators of Hgb, MCV, and white blood cell cell did
not display concentration-dependence on BPb levels.
Some confounders such as menstruation, smoking, and
working status may influence the relationships between
BPb and hematological indicators.
In this study, the BMD model gave us an opportunity to
estimate the critical effect dose for BPb-associated anemia
in workers. BMD modeling has been utilized as a more
precise mathematical approach for performing toxico-
logical risk assessment [24]. Compare to the traditional
method of using NOAEL (No observed adverse effect
level) or LOAEL (Lowest observed adverse effect level),
BMD modeling can be further applied to model prediction
in the toxicological and epidemiological investigation.
Overall, the BMD models provide more accurate and
precise value by using the computational approach,
Fig. 4 Forest plot showing the estimated hazard index with 95% confidence intervals and relative risk contribution for each working group.
Female workers are represented by light gray
Fig. 5 Bayesian analysis-based ORs determining the available of calculated BMD10 as novel BPb limit. Bars indicate 95% confidence intervals.
Dotted line, null value (OR = 1.0)
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which considers the uncertainty from the epidemio-
logical information and mathematical models. Our re-
sults show that BMD10 and BMDL10 estimates ranged
from 23 to 87 and 15–48 μg/dL for male workers after
adjusting for of age and working years. Our estimation
of BMD10 was similar to those reported by Karita et al.
[16], which ranged from 48 to 73 μg/dL. Further, our
BMDL10 estimates were consistent with their results,
which ranged from 33 to 49 μg/dL.
According to the recent statement from American
College of Occupational and Environmental Medicine
(ACOEM), BPb is still a reliable and wide-used biomoni-
toring indicator for the health effects associated with
lead exposure. The most compelling epidemiology evi-
dence shows that the increased cardiovascular morbidity
and mortality in populations with BPb in the low to
medium range of 10 to 20 μg/dL [25, 26]. The most not-
able effect is the increased cardiovascular risks at these
BPb levels, but the adverse pregnancy outcomes and
other effects may also occur.
Risk assessment results demonstrated that lead
workers are likely to work in unsafe workplaces. Un-
acceptable hazard occurrence probability was approxi-
mately 11.1% for total lead workers. Female workers in
the assembling group had a higher risk of 79.5%, result-
ing in hematological effects, which may exceed the ac-
ceptable level. Risk contribution was 31.5% within total
lead workers. However, the highest hazard contribution
in male lead workers was estimated at only 9.5% in the
grinding group. It seems that appropriate engineering
control measures and hygiene strategies still play an im-
portant role in limiting lead exposure for female lead
workers [27].
To determine whether the estimated critical values of
BPb can be used as the novel limit for health manage-
ment, this study successfully applied a Bayesian analysis
approach integrated with MC simulation to estimate the
uncertainty and reliability of risk control efficiency. Our
approach had also been widely used in exposure analysis
and risk decision-making in environmental and occupa-
tional health research [28, 29].
To determine the BPb levels in health management,
we examined the simulated BPbs that were set at 25 and
35 μg/dL for male workers. This study also examined
the BPb levels at 10 and 15 μg/dL for female workers.
Our results found out that there were slight differences
when considering these two BPb levels for male workers.
Although the ORs and hazard prevention probabilities
of a BPb level at 25 μg/dL were higher than those of a
BPb level at 35 μg/dL, it seems that the improving effi-
ciency had reached the theoretical level. Therefore, the
suitable BPb level of male workers for health manage-
ment of anemia can be set in this interval. The BPb-
hematological BMDs for female workers were lower than
male, indicating that female workers are more vulnerable
for lead-related anemia than male. We found that BPb
level at 15 μg/dL could be used as a suitable health man-
agement limited rather than 10 μg/dL.
Our results also revealed that 95% CIs of Bayesian
analysis-based ORs all cover the value of 1, indicating
that the risk control efficiency may be slightly insignifi-
cant. However, the results from hazard prevention prob-
abilities showed that there were nearly 50–70%
probabilities of improving the lead-related anemia by
restraining BPb limit up to 25–35 μg/dL for male
workers. The hazard prevention probabilities for female
workers were 85.5–95.0% when BPb limit of 15 μg/dL
was adopted. Thus, the anemia risk can also be reduced
when a more stringent BPb level is adopted.
Limitations and implications
Our study provides the health protection guideline of
BPb level in lead workers, which can be used to quantify
anemia risk associated with lead exposure. This study
did not focus on the exposure assessment of airborne
lead. Compared with environmental monitoring of air-
borne lead concentration and permissible exposure level,
BPb is more reliable and can be used to determine
gender-specific health effects of lead. In addition, the air-
borne lead cannot fully reflect the health risk if the com-
pany successfully implements personal protection
equipment and industrial hygiene.
This study could not investigate and control the other
possible sources of lead exposure outside the work and
get the complete information on previous experience of
lead-related work. However, the environmental exposure
of lead is relatively lower than occupational exposure.
This study focuses on the dose-response relationship be-
tween BPb concentration and the hematological indica-
tors from regular health examination. The BPb was
mainly sourced from the current workplace. Therefore,
we assumed that the cumulative BPb that sourced from
workplace or other area can be associated with the
change of the hematological indicators.
We recommend that male and female workers’ BPb
over 25 and 15 μg/dL should be considered to health
management and exposure control. Lead-exposed
workers need to be continuously controlled and reduce
their BPb even if levels are under the current limits of
40/30 μg/dL for male/female workers. Flora et al. [30]
reported that BPb levels of 10–20 μg/dL could precipi-
tate anemia. The possible threshold of lead-associated
anemia was also proposed by previous studies, which
was approximately 20 μg/dL for lead workers [11, 16].
By contrast, our study found that BPb-related
hematological effects may display gender-specificity due
to inter-individual variability. Furthemore, there is no
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evidence of a safe exposure level for renal and cardiac
effects associated with exposure to lead [31, 32].
According to our correlation analysis, we found that
BPb had significantly negative correlations with
hematological indicators in male workers. However, this
correlation was not observed in female workers. This
result might due to the fact that female workers had
relatively lower BPb levels compared to males. More-
over, we were unable to collect information about the
menstruation or pregnancy from our collated data for
female workers. This data gap may influence our risk
estimation results. The constructed dose-response rela-
tionship was an atypical S-shape in our effect analysis.
We observed some abnormal hematological indicators
in female workers who had lower BPb concentrations,
an effect which may have been due to menstruation or
pregnancy. Nonetheless, BPb levels in female workers
needs to be carefully revised in order to prevent the
lead-related anemia risk.
In addition to hematological effects of anemia, health
effects of low-dose lead also include hypertension, cog-
nitive dysfunction, renal, and reproductive effects.
Lead may also be genotoxic [33, 34]. Neuropsycho-
logical effects of lead toxicity were also determined to
be a common occupational hazard of lead toxicity [35].
Neurotoxic effects in lead-exposed workers were ob-
served at BPb level below 20 μg/dL, which was a more
sensitive toxicity phenotype compared to other lead-
induced adverse effects. Ahmad et al. [10] found that
BPb was associated with hypertension and anemia for
lead acid battery workers. Therefore, lead workers
might suffer from illnesses associated with low-level
lead exposure.
Computational approaches are a useful research tool in
the health risk assessment of chemical exposure, including
heavy metal [36]. A computational modeling approach
was used to estimate airborne lead concentrations by
using BPb levels [37]. OEHHA [37] used a computational
approach and recommended that the BPb level should be
between 5 to 10 μg/dL for workers over 40 years of work-
ing in a factory. Thus, the 8-h time-weighted-average air-
borne lead concentrations must not exceed 2.1 μg/m3.
The permissible exposure limit (PEL) is 50 μg/m3 in
Taiwan. Therefore, stringent PEL and personal hygiene
strategy should be considered to reduce exposure to air-
borne lead.
Our study found that female workers had lower lead
effect dose than male workers, suggesting that, com-
pared to males, female workers are likely to have a
higher risk of lead-induce anemia. In Taiwan, the Occu-
pational Safety and Health Act suggests that pregnant
women should stop working in the current lead-exposed
workplace and prohibits them to work until one year
after childbirth. Kosnett [8] recommended that women
who are or may become pregnant and have a
BPb > 5 μg/dL should reduce their exposure to lead.
This study applied the model averaging method to in-
tegrate BMD estimates across multiple models. It has
been used as an effective method for estimating the
model uncertainty in BMD estimation. The model aver-
aging method has also been widely applied to dichotom-
ous dose-response relationships in a variety of risk
assessment contexts such as occupational and epidemio-
logical studies [38, 39]. However, several limitations may
affect the accuracy of BMD estimation. Wheeler and
Bailer [38] indicated that the “average-model” method
often failed to adequately cover the true BMD when a
linear or near linear dose-responses was modeled. The
model averaging and the corresponding BMD and
BMDL are potentially biased in low-dose scenarios.
The observed average BPb levels were much lower
than the current health management limits in this study.
However, this study still found some workers with
hematological effects even though the BPb were under
the permissible level. The proportions of lead working
population with abnormal hematological indicators were
estimated >10% in each job category. Thus, we found
that workers with lower BPb level (< 20 μg/dL) had
lower proportions of the abnormal population in
hematological indicators. We also found out that some
lead workers may still work in an unsafe condition with
risk estimates of HI > 1, especially for female workers. It
would be better to establish a new occupational strategy
and enhance the education and training to reduce the
BPb concentrations and subsequent hematotoxicity.
Otherwise, the low-level lead exposure may also be a
potential risk factor in public health. Our research
framework can also be applied to assess other lead
induced-adverse health effects in exposed population.
Furthermore, a long-term follow-up investigation is ur-
gently needed to characterize lead-associated adverse
health effects.
Conclusions
This study showed that hematopoietic effects for male
and female lead-exposed workers are observed even
when BPb concentrations were under the current health
management levels. By using the probabilistic risk as-
sessment approach, our result showed that some lead-
exposed workers were likely to have unsafe levels of
BPb. The BMDs for lead exposed-induced health effects
provided the novel limits on BPb for health manage-
ment. Our results suggest that the current BPb limit
needs to be better characterized to better protect the
health of lead-exposed population. Low-level lead expos-
ure risk is an occupational and public health problem
that should be paid more attention.
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